SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 485 filers reported holding SEAGEN INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $436,180 | -12.7% | 2,056 | -20.8% | 0.34% | +2.1% |
| Q2 2023 | $499,434 | -4.2% | 2,595 | +0.7% | 0.33% | -10.4% |
| Q1 2023 | $521,563 | +54.3% | 2,576 | -2.2% | 0.37% | +30.2% |
| Q4 2022 | $338,000 | +1.2% | 2,633 | +7.9% | 0.28% | -0.7% |
| Q3 2022 | $334,000 | -83.4% | 2,440 | -78.5% | 0.28% | -38.6% |
| Q2 2022 | $2,007,000 | +316.4% | 11,342 | +239.3% | 0.46% | +41.8% |
| Q1 2022 | $482,000 | -19.4% | 3,343 | -13.6% | 0.32% | -19.6% |
| Q4 2021 | $598,000 | -8.3% | 3,871 | +0.8% | 0.40% | -10.2% |
| Q3 2021 | $652,000 | +15.4% | 3,839 | +7.4% | 0.45% | +16.9% |
| Q2 2021 | $565,000 | +32.6% | 3,576 | +16.4% | 0.38% | -8.6% |
| Q1 2021 | $426,000 | +61.4% | 3,071 | +104.1% | 0.42% | +32.0% |
| Q4 2020 | $264,000 | – | 1,505 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |